814 related articles for article (PubMed ID: 24898698)
1. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.
Kelly LP; Carvey PM; Keshavarzian A; Shannon KM; Shaikh M; Bakay RA; Kordower JH
Mov Disord; 2014 Jul; 29(8):999-1009. PubMed ID: 24898698
[TBL] [Abstract][Full Text] [Related]
2. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary study on time-dependent changes of intestinal tract and brain-gut axis in mice model of Parkinson's disease induced by paraquat].
Wang KD; Zhang BY; Zhang BF; Huang M
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2022 Mar; 40(3):161-169. PubMed ID: 35439855
[No Abstract] [Full Text] [Related]
4. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
[TBL] [Abstract][Full Text] [Related]
5. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease.
Forsyth CB; Shannon KM; Kordower JH; Voigt RM; Shaikh M; Jaglin JA; Estes JD; Dodiya HB; Keshavarzian A
PLoS One; 2011; 6(12):e28032. PubMed ID: 22145021
[TBL] [Abstract][Full Text] [Related]
6. No enhanced (p-) α-synuclein deposition in gastrointestinal tissue of Parkinson's disease patients.
Harapan BN; Frydrychowicz C; Classen J; Wittekind C; Gradistanac T; Rumpf JJ; Mueller W
Parkinsonism Relat Disord; 2020 Nov; 80():82-88. PubMed ID: 32971383
[TBL] [Abstract][Full Text] [Related]
7. Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve.
Uemura N; Yagi H; Uemura MT; Hatanaka Y; Yamakado H; Takahashi R
Mol Neurodegener; 2018 May; 13(1):21. PubMed ID: 29751824
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models.
Su Y; Liu N; Zhang Z; Li H; Ma J; Yuan Y; Shi M; Liu J; Zhao Z; Zhang Z; Holscher C
Eur J Pharmacol; 2022 Jul; 926():175029. PubMed ID: 35584709
[TBL] [Abstract][Full Text] [Related]
9. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease.
George S; Rey NL; Tyson T; Esquibel C; Meyerdirk L; Schulz E; Pierce S; Burmeister AR; Madaj Z; Steiner JA; Escobar Galvis ML; Brundin L; Brundin P
Mol Neurodegener; 2019 Aug; 14(1):34. PubMed ID: 31419995
[TBL] [Abstract][Full Text] [Related]
10. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.
Barrenschee M; Zorenkov D; Böttner M; Lange C; Cossais F; Scharf AB; Deuschl G; Schneider SA; Ellrichmann M; Fritscher-Ravens A; Wedel T
Acta Neuropathol Commun; 2017 Jan; 5(1):1. PubMed ID: 28057070
[TBL] [Abstract][Full Text] [Related]
11. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
[TBL] [Abstract][Full Text] [Related]
12. Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation.
Wang L; Magen I; Yuan PQ; Subramaniam SR; Richter F; Chesselet MF; Taché Y
Neurogastroenterol Motil; 2012 Sep; 24(9):e425-36. PubMed ID: 22779732
[TBL] [Abstract][Full Text] [Related]
13. Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice.
Kishimoto Y; Zhu W; Hosoda W; Sen JM; Mattson MP
Neuromolecular Med; 2019 Sep; 21(3):239-249. PubMed ID: 31079293
[TBL] [Abstract][Full Text] [Related]
14. Intestine-derived α-synuclein initiates and aggravates pathogenesis of Parkinson's disease in Drosophila.
Liu W; Lim KL; Tan EK
Transl Neurodegener; 2022 Oct; 11(1):44. PubMed ID: 36253844
[TBL] [Abstract][Full Text] [Related]
15. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.
Gao HM; Zhang F; Zhou H; Kam W; Wilson B; Hong JS
Environ Health Perspect; 2011 Jun; 119(6):807-14. PubMed ID: 21245015
[TBL] [Abstract][Full Text] [Related]
16. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
[TBL] [Abstract][Full Text] [Related]
17. Age-Dependent Alpha-Synuclein Accumulation and Phosphorylation in the Enteric Nervous System in a Transgenic Mouse Model of Parkinson's Disease.
Zhong CB; Chen QQ; Haikal C; Li W; Svanbergsson A; Diepenbroek M; Li JY
Neurosci Bull; 2017 Oct; 33(5):483-492. PubMed ID: 28924920
[TBL] [Abstract][Full Text] [Related]
18. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A
Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897
[TBL] [Abstract][Full Text] [Related]
19. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
[TBL] [Abstract][Full Text] [Related]
20. Squalamine Restores the Function of the Enteric Nervous System in Mouse Models of Parkinson's Disease.
West CL; Mao YK; Delungahawatta T; Amin JY; Farhin S; McQuade RM; Diwakarla S; Pustovit R; Stanisz AM; Bienenstock J; Barbut D; Zasloff M; Furness JB; Kunze WA
J Parkinsons Dis; 2020; 10(4):1477-1491. PubMed ID: 32925094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
